ENTITY
Genscript Biotech

Genscript Biotech (1548 HK)

57
Analysis
Health CareHong Kong
Genscript Biotech Corp is biotech service company. The Company provides life science services and products and pre-clinical drug development services.
more
Refresh
bullishWuxi Biologics
19 Jun 2018 19:46

Wuxi Biologics Placement - Probably Not a Surprise to Sell Again when Lock-Up Expires

Biologics Holdings is looking to sell 50m shares of WuXi Biologics (Cayman) Inc. (2269 HK) worth about US$500m. Post sale, Biologics Holdings will...

Share
04 Jun 2018 20:10

Genscript Biotech Placement - Raising Money to Build Up CAR-T R&D and Production Facilities

Genscript Biotech Corp (1548 HK) is looking to raise US$304m by selling 90m shares (including 15m top-up primary shares). This is a concurrent...

Share
24 Mar 2017 16:32

Energy Medicine. Personal Experience. Impact. Growth in Asia. Ideas

This is an invest-able idea at the private level  with long term benefits. Both for the body, and for other ideas as well.Ever since I turned over...

Share
18 Dec 2015 15:45

Genscript Biotech IPO - Financial Track Record Doesn't Inspire Much Confidence

Genscript Biotech (GS) plans to raise US$70-90m through its IPO. This is a follow up note to Kemp Dolliver, CFA 's insight An Intriguing Small Cap...

Logo
375 Views
Share
18 Dec 2015 11:04

An Intriguing Small Cap with Price Risk

SummaryGenscript Biotech (1548 HK) is a pending small cap healthcare IPO.  We think Genscript is a very interesting company because of its leading...

Share
x